“…Moreover, only very limited data are available on the long-term oncological outcomes and complications in patients treated with RRH for cervical cancer. 9 Because most previous studies evaluating the learning curve of RRH for early-stage cervical cancer have focused on short-term outcomes, such as operative time, complications, and conversion rate, 10,11 very little is known about the long-term oncological outcomes of RRH during the initial learning period.…”